BDBM264465 5-(2-(pyridazin-4-yl)-4-(trifluoromethyl)phenoxy)-2-(thiazol-2-yl)-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide::US9714252, 1

SMILES FC(F)(F)c1ccc(Oc2ccc3c(CN(c4nccs4)S3(=O)=O)c2)c(c1)-c1ccnnc1

InChI Key InChIKey=WQLXCLXPLWQRBB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 264465   

TargetSodium channel protein type 9 subunit alpha(Human)
Purdue Pharma

US Patent
LigandPNGBDBM264465(5-(2-(pyridazin-4-yl)-4-(trifluoromethyl)phenoxy)-...)
Affinity DataIC50: 1.74E+3nMAssay Description:Representative Compounds of the Invention have been tested in the FLIPR, FLIPRTETRA, and/or electrophysiology (EP) assays for sodium channel blocking...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2018
Entry Details
Go to US Patent